Flu Pandemic Preparedness: Detection of the Potentially Pandemic G4 EA Avian-Like H1N1 Strains Using QIAstat-Dx Respiratory SARS-CoV-2 Panel

Abstract A recent publication by Sun H. and colleagues in the Proceedings of the National Academy of Science (PNAS) has drown global attention to the predominant genotype “G4” Eurasian (EA) avian-like H1N1 Influenza A virus that has been spreading among pigs in China since 2016, which is predicted to have a significant pandemic potential. Since pigs are hosts for the generation of pandemic Influenza A viruses (IAVs), surveillance and preparedness are critical to prevent pandemics. In this regards, one distinguishing feature of the QIAstat-Dx® Respiratory SARS-CoV-2 panel is the double target approach Influenza A detection of seasonal strains affecting humans, by amplification of a generic Influenza A assay plus one of the specific assays discriminating H3, H1 and H1N1pdm09 subtypes. The generic Influenza A assay is designed to amplify any IAV, a key feature for preparedness. Here we report an initial in-silico analysis that predicts that the G4 EA avian-like H1N1 strains tested in the QIAstat-Dx® Respiratory SARS-CoV-2 Panel would be detected yielding a positive result for the generic Influenza A assay and negative results for the seasonal H3, H1 and H1N1pdm09 assays. This prediction was confirmed in-vitro using dsDNA fragments mixed to mimic the genomes of the different reported G4 EA IAV strains. In conclusion, the QIAstat-Dx® Respiratory SARS-CoV-2 Panel could be a useful tool to differentially diagnose zoonotic strains from the seasonal Influenza A strains commonly affecting humans.